Cargando…

Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Self-amplifying RNA (saRNA) is a next-generation vaccine platform, but like all nucleic acids, requires a delivery vehicle to promote cellular uptake and protect the saRNA from degradation. To date, delivery platforms for saRNA have included lipid nanoparticles (LNP), polyplexes and cationic nanoemu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blakney, Anna K., McKay, Paul F., Hu, Kai, Samnuan, Karnyart, Jain, Nikita, Brown, Andrew, Thomas, Anitha, Rogers, Paul, Polra, Krunal, Sallah, Hadijatou, Yeow, Jonathan, Zhu, Yunqing, Stevens, Molly M., Geall, Andrew, Shattock, Robin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412240/ https://www.ncbi.nlm.nih.gov/pubmed/34418521 http://dx.doi.org/10.1016/j.jconrel.2021.08.029

Ejemplares similares

Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA
por: Blakney, Anna K., et al.
Publicado: (2021)

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
por: McKay, Paul F., et al.
Publicado: (2020)

Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer
por: Blakney, Anna K., et al.
Publicado: (2020)

Presentation of antigen on extracellular vesicles using transmembrane domains from viral glycoproteins for enhanced immunogenicity
por: Hu, Kai, et al.
Publicado: (2022)

An Update on Self-Amplifying mRNA Vaccine Development
por: Blakney, Anna K., et al.
Publicado: (2021)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
por: Spencer, Alexandra J., et al.
Publicado: (2021)

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets
por: McKay, P F, et al.
Publicado: (2022)

A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model
por: Frise, Rebecca, et al.
Publicado: (2022)

Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
por: van de Berg, Damien, et al.
Publicado: (2021)

The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants
por: Blakney, Anna K., et al.
Publicado: (2019)

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
por: Shattock, Robin John, et al.
Publicado: (2023)

Structural Components for Amplification of Positive and Negative Strand VEEV Splitzicons
por: Blakney, Anna K., et al.
Publicado: (2018)

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery
por: Hu, Kai, et al.
Publicado: (2022)

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
por: Blakney, Anna K., et al.
Publicado: (2019)

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines
por: Tregoning, John S., et al.
Publicado: (2022)

Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
por: Aldon, Yoann, et al.
Publicado: (2021)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013)

A duplex droplet digital PCR assay for absolute quantification and characterization of long self-amplifying RNA
por: Casmil, Irafasha C., et al.
Publicado: (2023)

OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines
por: Duhen, Rebekka, et al.
Publicado: (2022)

Detection and Typing of Human Enteroviruses from Clinical Samples by Entire-Capsid Next Generation Sequencing
por: Majumdar, Manasi, et al.
Publicado: (2021)

Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis
por: Mitchell, Michael J., et al.
Publicado: (2017)

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
por: Magini, Diletta, et al.
Publicado: (2016)

An Overview of Rift Valley Fever Vaccine Development Strategies
por: Kitandwe, Paul Kato, et al.
Publicado: (2022)

Reinventing the nucleic acid vaccine with self-amplifying RNA
por: Geall, AJ, et al.
Publicado: (2012)

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non–Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae
por: Aldon, Yoann, et al.
Publicado: (2020)

A systematic analysis of the expression of the anti-HIV VRC01 antibody in Pichia pastoris through signal peptide optimization
por: Aw, Rochelle, et al.
Publicado: (2018)

Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastoris
por: Aw, Rochelle, et al.
Publicado: (2017)

Photoinitiated Polymerization‐Induced Self‐Assembly (Photo‐PISA): New Insights and Opportunities
por: Yeow, Jonathan, et al.
Publicado: (2017)

Estimation of Seasonal Influenza Attack Rates and Antibody Dynamics in Children Using Cross-Sectional Serological Data
por: Minter, Amanda, et al.
Publicado: (2020)

Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity
por: Mann, Jamie F. S., et al.
Publicado: (2021)

Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers
por: Sun, Chun-Yang, et al.
Publicado: (2018)

Determination of the Best Empiric Method to Quantify the Amplified Spontaneous Emission Threshold in Polymeric Active Waveguides
por: Milanese, Stefania, et al.
Publicado: (2020)

Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T- and B-cell responses
por: Bogers, WM, et al.
Publicado: (2012)

Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice
por: Mann, Jamie F. S., et al.
Publicado: (2013)

Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection()
por: Mann, Jamie F.S., et al.
Publicado: (2013)

Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice
por: King, Deborah F. L., et al.
Publicado: (2015)

Discrete partitioning of HIV-1 Env forms revealed by viral capture
por: Stieh, Daniel J., et al.
Publicado: (2015)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2018)

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5avnlcnc0boasefolcm50vdset